An official website of the United States government
Home
Name
Tam Exemestane
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for Tam Exemestane
Name
Alternate Names
Alpha-Tamoxifen
Apo-Tamox
Dom-Tamoxifen
Gen-Tamoxifen
ICI-46474
Nolvadex
Nolvadex-D
Novo-Tamoxifen
PMS-Tamoxifen
Tamofen
Tamone
Tamoplex
Tamoxifen
Tamoxifen Citrate
Soltamox
Abbreviations
TAM
TMX
Category
Hormones and hormonal mechanisms
Subcategory
Nonsteroidal antiestrogen
NSC Number
180973
Primary Site
Breast
Histology
None
Remarks
A nonsteroidal antiestrogenic agent with combined partial-estrogen-agonist activity. FDA approved uses on breast cancer and risk reduction for women with high risk of developing breast cancer.
Literature shows that Tamoxifen is being prescribed for recurrent/relapsed ovarian cancer.
Literature shows that Tamoxifen is being prescribed for recurrent/relapsed ovarian cancer.
Coding
This drug should be coded
Name
Alternate Names
Aromasin
FEC 24304
FEC-24304
FEC24304
Nikidess
PNU 155971
PNU-155971
PNU155971
Abbreviations
None
Category
Hormones and hormonal mechanisms
Subcategory
Aromatase inhibitor
NSC Number
713563
Primary Site
Breast
other cancer
Histology
None
Remarks
FDA approved postmenopausal breast cancer; Phase II/III for other sites Steroidal aromatase inhibitor. Pharmacia, Pfizer. For adjuvant treatment of postmenopausal women with ER positive breast cancer who have completed 2-3 years of tamoxifen for completion of a total of 5 consecutive years of adjuvant hormonal therapy.
Coding
This drug should be coded
